Clinical Trials Logo

Filter by:
NCT ID: NCT00225030 Completed - Hypertension Clinical Trials

Observational Study of the Prognosis in Treated Arterial Hypertension

Start date: January 1970
Phase: N/A
Study type: Observational

Observational study of life time prognosis for persons medically treated for arterial hypertension, according to current WHO-guidelines.

NCT ID: NCT00224991 Completed - Osteoporosis Clinical Trials

Osteoporosis School

Start date: June 1999
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of systematic education (osteoporosis school) on fall frequency, compliance and quality of life of a group of patients more than fifty years of age. Hypothetically, systematic information can increase compliance to the medical treatment, decrease the frequency of falls and increase the quality of life.

NCT ID: NCT00224484 Completed - Herpes Simplex Clinical Trials

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Start date: April 7, 2004
Phase: Phase 3
Study type: Interventional

Main goal of this study is to compare the occurrence of serious adverse events (SAEs) between the herpes simplex (gD2-AS04) vaccine group and the Saline control group throughout the study period (up to month 12). The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

NCT ID: NCT00216879 Completed - Psoriasis of Scalp Clinical Trials

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Start date: February 2005
Phase: Phase 3
Study type: Interventional

The purpose of the trial is to study the safety and efficacy of long term use of once daily applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to calcipotriol alone in the same gel. The primary response criteria will be the incidence of adverse drug reactions of any type, and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp.

NCT ID: NCT00216827 Completed - Psoriasis of Scalp Clinical Trials

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and more effective than betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle, calcipotriol 50 mcg/g in the gel vehicle or the gel vehicle used alone in patients with scalp psoriasis. The primary outcome is the proportion of patients with absence of disease or very mild disease after 8 weeks of treatment.

NCT ID: NCT00216671 Completed - Schizophrenia Clinical Trials

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Start date: November 2005
Phase: Phase 4
Study type: Interventional

The primary objective of this randomized trial was to investigate whether early initiation of treatment with Risperdal Consta after an acute episode was not inferior to the routine approach (oral treatment for 12 weeks followed by treatment with Risperdal Consta). .

NCT ID: NCT00216619 Completed - Migraine Clinical Trials

The Prolonged Use of Topiramate for Preventing Migraine Headaches

PROMPT
Start date: November 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness (beyond 6 months) of individualized doses (100 to 200 milligrams) of topiramate for the prevention of migraine headaches over a period of 26 weeks.

NCT ID: NCT00216476 Completed - Schizophrenia Clinical Trials

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a long-acting injectable formulation of risperidone provides better effectiveness over 2 years, as measured by the time to relapse, compared with quetiapine tablets in a routine psychiatric care setting. Aripiprazole will be investigated in a descriptive manner.

NCT ID: NCT00215696 Completed - Clinical trials for Moderate to Severe Angina Pectoris

A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies

Start date: April 2005
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to determine whether treatment with an experimental gene therapy (BIOBYPASS®) will reduce angina in study participants by stimulating the growth of new blood vessels. This will be measured by testing whether participants are able to exercise longer without experiencing angina after treatment, as compared to before treatment. Additionally, this study will collect information about any side effects that might be related to the treatment with the experimental therapy.

NCT ID: NCT00215592 Completed - Epilepsy Clinical Trials

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

Start date: October 2005
Phase: Phase 4
Study type: Interventional

To determine the efficacy and safety of adjunctive open label Zonegran treatment in patients with refractory partial seizures.